AIST offers conditional support for this Bill, however we point out that the Bill goes against international best practice by exempting product manufacturers, as well as relying on a flawed disclosure and reporting framework. AIST believes that further carveouts are not in fund members’ best interests. AIST is also uncertain what might constitute a trigger for a target market review.